| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | GLP-1|Glucagon Like Peptide 1|GLP1|GCG|GLP1|GLP2|GRPP|glicentin-related polypeptide|GLP2|glucagon|glucagon-like peptide 2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
rat GLP-1 (Glucagon Like Peptide 1) is a molecular target commonly studied in immunology, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of GLP-1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of GLP-1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
GLP-1 (Glucagon Like Peptide 1) may also be referenced as GLP-1, Glucagon Like Peptide 1, and GLP1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how GLP-1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, signal transduction, and neuroscience research.
- Interpreting shifts in GLP-1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
GLP-1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Omarigliptin/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and p38/ERK/JNK MAPKs
IF: 3.2 Journal: Human & Experimental Toxicology Author: Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia. Cited Date: 2025-11-07
The possible renoprotective effect of denatonium benzoate in a rat model of type 2 diabetes: role of Krüppel-like factor 6 (KLF6)
IF: 3.1 Journal: Naunyn-Schmiedeberg's Archives of Pharmacology Author: Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Cited Date: 2025-11-14
Liraglutide and denatonium benzoate attenuate T2DM-induced metabolic, neurological, and testicular changes in rats: Targeting oxidative stress, inflammation, and BCRP transporter
IF: 2.9 Journal: Journal of Molecular Histology Author: Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Cited Date: 2025-02-07
Effects of Single or Combined Supplementation of Probiotics and Zinc on Histological Features of Ileum, Glucagon Like Peptide-1 and Ghrelin Levels in Malnourished Rats
IF: Journal: Folia Medica Cited Date: 2021-03-11
Exploration of Antidiabetic Activity of the Whole Plant Extract of Eclipta prostrata by In Silico, In Vitro, and In Vivo Methods
IF: Journal: Avicenna Journal of Medical Biochemistry Author: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh Cited Date: 2025-02-14
Lactiplantibacillus plantarum LAB12 Induced Neuroprotection Through the Gut-Brain Axis
IF: Journal: Science Letters Author: Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia Cited Date: 2023-07-07